| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.37 | 0.009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.002 |